Friulchem SpA
MIL:FCM
Friulchem SpA
MIL:FCM
Price:
0.81
EUR
2.53%
Market Closed
Market Cap:
€6.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Friulchem SpA
MIL:FCM
|
IT |
|
RTL Group SA
XETRA:RRTL
|
LU |
|
Gujarat Alkalies And Chemicals Ltd
NSE:GUJALKALI
|
IN |
|
Csam Health Group AS
OSE:CSAM
|
NO |
|
B
|
Banca Intermobiliare di Investimenti e Gestioni SpA
MIL:BIM
|
IT |
|
A
|
Apollo Healthcare Corp
TSX:AHC
|
CA |
|
Barratt Redrow PLC
LSE:BTRW
|
UK |
|
D
|
Donkeyrepublic Holding A/S
CSE:DONKEY
|
DK |
|
Corporacion Actinver SAB de CV
BMV:ACTINVRB
|
MX |
|
First Financial Northwest Inc
NASDAQ:FFNW
|
US |
|
Insignia Financial Ltd
ASX:IFL
|
AU |
Balance Sheet
Balance Sheet Decomposition
Friulchem SpA
Friulchem SpA
Balance Sheet Decomposition is not available for
Friulchem SpA
Friulchem SpA
Balance Sheet
Friulchem SpA
Friulchem SpA
Currency: EUR
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
1
|
2
|
5
|
4
|
18
|
14
|
5
|
|
| Cash |
0
|
1
|
2
|
5
|
4
|
9
|
7
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
9
|
7
|
5
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
5
|
5
|
3
|
4
|
3
|
5
|
9
|
5
|
|
| Accounts Receivables |
5
|
5
|
3
|
3
|
1
|
4
|
9
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Inventory |
2
|
2
|
2
|
2
|
2
|
6
|
8
|
7
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
7
|
7
|
7
|
10
|
9
|
19
|
25
|
17
|
|
| PP&E Net |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
6
|
|
| PP&E Gross |
2
|
2
|
2
|
2
|
2
|
0
|
2
|
0
|
|
| Accumulated Depreciation |
5
|
6
|
6
|
6
|
7
|
0
|
8
|
0
|
|
| Intangible Assets |
7
|
6
|
7
|
8
|
8
|
9
|
10
|
12
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
17
N/A
|
16
-2%
|
16
0%
|
20
+25%
|
21
+3%
|
32
+54%
|
39
+21%
|
37
-5%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
2
|
7
|
13
|
10
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
5
|
4
|
2
|
2
|
2
|
2
|
3
|
5
|
|
| Other Current Liabilities |
2
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
|
| Total Current Liabilities |
7
|
6
|
4
|
3
|
6
|
12
|
18
|
18
|
|
| Long-Term Debt |
1
|
2
|
2
|
2
|
4
|
9
|
9
|
8
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
5
|
4
|
4
|
5
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
13
N/A
|
12
-3%
|
10
-18%
|
9
-6%
|
10
+10%
|
22
+107%
|
28
+32%
|
27
-6%
|
|
| Equity | |||||||||
| Common Stock |
4
|
4
|
6
|
6
|
6
|
6
|
6
|
6
|
|
| Retained Earnings |
0
|
0
|
1
|
1
|
0
|
1
|
0
|
0
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
4
|
4
|
4
|
4
|
4
|
|
| Total Equity |
4
N/A
|
4
+1%
|
6
+53%
|
11
+74%
|
10
-3%
|
11
+1%
|
10
-1%
|
10
-3%
|
|
| Total Liabilities & Equity |
17
N/A
|
16
-2%
|
16
0%
|
20
+25%
|
21
+3%
|
32
+54%
|
39
+21%
|
37
-5%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
4
|
4
|
6
|
8
|
8
|
6
|
6
|
6
|
|
Switch to:
Switch to:
See Also
Discover More
